Atrial fibrillation is associated with decreased total cerebral blood flow and brain perfusion

Aims Atrial fibrillation (AF) has been associated with cognitive impairment. Additionally, brain volume may be reduced in individuals with AF. Potential causes may include cerebral micro-embolism or reduced stroke volume due to the beat-to-beat variation in AF. The aims of this study were to measure cerebral blood flow and estimate whole brain perfusion in elderly individuals with and without AF. Methods and results Blood flow in the cervical arteries was measured with phase contrast MRI and brain perfusion estimated in a large cohort from the AGES-Reykjavik Study. Individuals were divided into three groups at the time of the MRI: persistent AF, paroxysmal AF, and no history of AF. Of 2291 participants (mean age 79.5 years), 117 had persistent AF and 78 had paroxysmal AF but were in sinus rhythm at the time of imaging AF. Those with persistent AF had lower cholesterol and used more anti-hypertensive medication and warfarin. The three groups were similar with regard to other cardiovascular risk factors. Those in the persistent AF group had significantly lower total cerebral blood flow on average, 472.1 mL/min, both when compared with the paroxysmal AF group, 512.3 mL/min (P < 0.05) and the no AF group, 541.0 mL/min (P < 0.001). Brain perfusion was lowest in the persistent AF group, 46.4 mL/100 g/min compared with the paroxysmal AF group, 50.9 mL/100 g/min in (P < 0.05) and those with no AF, 52.8 mL/100 g/min (P < 0.001). Conclusion Persistent AF decreases blood flow to the brain as well as perfusion of brain tissue compared with sinus rhythm.

[1]  M. Endres,et al.  Does atrial fibrillation cause cognitive decline and dementia? , 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[2]  P. Kirchhof,et al.  2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. , 2016, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[3]  P. Kirchhof,et al.  2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[4]  Vilmundur Gudnason,et al.  Feasibility of Using Pseudo-Continuous Arterial Spin Labeling Perfusion in a Geriatric Population at 1.5 Tesla , 2015, PloS one.

[5]  J. Morley,et al.  Atrial fibrillation: A major risk factor for cognitive decline. , 2015, American heart journal.

[6]  W. Haverkamp,et al.  Improvement of cerebral oxygen saturation after successful electrical cardioversion of atrial fibrillation. , 2014, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[7]  V. Gudnason,et al.  Atrial Fibrillation is Associated With Reduced Brain Volume and Cognitive Function Independent of Cerebral Infarcts , 2013, Stroke.

[8]  S. Kalantarian,et al.  Cognitive Impairment Associated With Atrial Fibrillation , 2013, Annals of Internal Medicine.

[9]  C. Ince,et al.  Electrical cardioversion for atrial fibrillation improves microvascular flow independent of blood pressure changes. , 2012, Journal of cardiothoracic and vascular anesthesia.

[10]  S. Popov,et al.  Ablation and Pacing: Improving Brain Perfusion and Cognitive Function in Patients with Atrial Fibrillation and Uncontrolled Ventricular Rates , 2012, Pacing and clinical electrophysiology : PACE.

[11]  Eric E. Smith,et al.  Cerebral microinfarcts: the invisible lesions , 2012, The Lancet Neurology.

[12]  Jesper Fredriksson,et al.  Brain tissue volumes in the general population of the elderly The AGES-Reykjavik Study , 2012, NeuroImage.

[13]  David Bonekamp,et al.  Quantitative cerebral blood flow in dynamic susceptibility contrast MRI using total cerebral flow from phase contrast magnetic resonance angiography , 2011, Magnetic resonance in medicine.

[14]  B. Horne,et al.  Atrial fibrillation is independently associated with senile, vascular, and Alzheimer's dementia. , 2010, Heart rhythm.

[15]  Wiro J. Niessen,et al.  Brain tissue volumes in relation to cognitive function and risk of dementia , 2010, Neurobiology of Aging.

[16]  G. Breithardt,et al.  Atrial fibrillation in stroke-free patients is associated with memory impairment and hippocampal atrophy. , 2008, European heart journal.

[17]  K. Safranow,et al.  Nonembolic, hemodynamic blood flow disturbances in the middle cerebral arteries in patients with paroxysmal atrial fibrillation without significant carotid stenosis , 2007, Clinical Neurology and Neurosurgery.

[18]  V. Gudnason,et al.  Age, Gene/Environment Susceptibility-Reykjavik Study: multidisciplinary applied phenomics. , 2007, American journal of epidemiology.

[19]  A Hofman,et al.  Atrial fibrillation and dementia in a population-based study. The Rotterdam Study. , 1997, Stroke.

[20]  F. Barkhof,et al.  Limited duration of the effect of methylprednisolone on changes on MRI in multiple sclerosis , 1994, Neuroradiology.

[21]  R. Totaro,et al.  Transcranial Doppler evaluation of cerebral blood flow in patients with paroxysmal atrial fibrillation , 1993, The Italian Journal of Neurological Sciences.

[22]  J. Kastrup,et al.  Cerebral Blood Flow before and after Cardioversion of Atrial Fibrillation , 1989, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[23]  R. Morawetz,et al.  Differential regional vulnerability in transient focal cerebral ischemia. , 1982, Stroke.

[24]  A. Keren,et al.  Effect of Chronic Atrial Fibrillation on Regional Cerebral Blood Flow , 1980, Stroke.